Linical Co News
News
0
Ticker
2183.T
ISIN
JP3974530002
Linical Co Eulerpool News
Linical Co Stock News
Linical Co is being monitored by journalists and investors worldwide. We gather the latest Linical Co news here.
Linical Co Stock Press Releases
Linical Co regularly publishes news on the company's website that are relevant for investors.
Linical Co News 2026
This page contains all current news, analysis and press releases for Linical Co stock (2183.T, ISIN: JP3974530002). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Linical Co.
Linical Co Stock
Linical Co Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services.